Buprenorphine Blocks ϵ- and μ-Opioid Receptor-Mediated Antinociception in the Mouse
@article{Mizoguchi2003BuprenorphineB, title={Buprenorphine Blocks ϵ- and $\mu$-Opioid Receptor-Mediated Antinociception in the Mouse}, author={Hirokazu Mizoguchi and Amanda Spaulding and Randy J. Leitermann and Hsiang-En Wu and Hiroshi Nagase and Leon F. Tseng}, journal={Journal of Pharmacology and Experimental Therapeutics}, year={2003}, volume={306}, pages={394 - 400} }
Antagonistic properties of buprenorphine for ϵ- and μ-opioid receptors were characterized in β-endorphin- and [d-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO)-induced antinociception, respectively, with the tail-flick test in male ICR mice. ϵ-Opioid receptor agonist β-endorphin (0.1–1 μg), μ-opioid receptor agonist DAMGO (0.5–20 ng), or buprenorphine (0.1–20 μg) administered i.c.v. dose dependently produced antinociception. The antinociception induced by 10 μg of buprenorphine given i.c.v. was…
18 Citations
Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic mu opioid and ORL1 receptor G protein coupling.
- BiologyBrain research. Developmental brain research
- 2004
Buprenorphine: a unique drug with complex pharmacology.
- Biology, MedicineCurrent neuropharmacology
- 2004
Evidence is provided demonstrating that the ORL-1 receptor plays a functional role not only in the antinociceptive effect of buprenorphine but also in other actions of the drug as well.
The history and pharmacology of buprenorphine: New advances in cats.
- Biology, MedicineJournal of veterinary pharmacology and therapeutics
- 2022
The history and pharmacology of buprenorphine relative to full opioid agonists, where appropriate, are examined, integrating these insights into advances within feline medicine.
Antinociceptive effects of intravenous administration of hydromorphone hydrochloride alone or followed by buprenorphine hydrochloride or butorphanol tartrate to healthy conscious cats.
- MedicineAmerican journal of veterinary research
- 2016
Butorphanol administration decreased the duration of antinociception achieved with hydromorphone administration in cats, and this opioid interaction and its impact on pain management require additional investigation.
Mechanism-Based Pharmacokinetic-Pharmacodynamic Modelling of the Reversal of Buprenorphine-Induced Respiratory Depression by Naloxone
- Biology, MedicineClinical pharmacokinetics
- 2007
Because of the slow receptor association-dissociation Kinetics of buprenorphine in combination with the fast elimination kinetics of naloxone, nal oxone is best administered as a continuous infusion for reversal of buPrenorphines-induced respiratory depression.
Interaction of μ‐opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice
- BiologyEuropean journal of pain
- 2005
Rational drug design and synthesis of a selective opioid receptor antagonist on the basis of the accessory site concept.
- Biology, ChemistryBioorganic & medicinal chemistry letters
- 2004
Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
- MedicineClinical therapeutics
- 2009
Advances in the delivery of buprenorphine for opioid dependence
- Medicine, BiologyDrug design, development and therapy
- 2017
Clinical trial data for novel buprenorphine delivery systems in the form of subcutaneous depot injections, transdermal patches, and subdermal implants for the treatment of OUD are reviewed and both the clinical efficacy of longer-acting formulations through increasing consistent medication exposure and their potential utility in reducing diversion are discussed.
References
SHOWING 1-10 OF 28 REFERENCES
Buprenorphine is a potent κ-opioid receptor antagonist in pigeons and mice
- Biology, Chemistry
- 1988
Antagonistic property of buprenorphine for putative ϵ-opioid receptor-mediated G-protein activation by β-endorphin in pons/medulla of the μ-opioid receptor knockout mouse
- Biology, ChemistryNeuroscience
- 2002
Antinociceptive effect of buprenorphine in mu1-opioid receptor deficient CXBK mice.
- Biology, PsychologyLife sciences
- 1997
Buprenorphine exerts its antinociceptive activity via mu 1-opioid receptors.
- Biology, PsychologyLife sciences
- 1995
β-Endorphin-(1–27) antagonizes β-endorphin- but not morphine-, D-PEN2-D-PEN2-enkephalin- and U50, 488H-induced analgesia in mice
- Biology, ChemistryNeuropharmacology
- 1988
The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat.
- Biology, Medicine
- 2002
It is reported for the first time that intrathecal buprenorphine is approximately 17 times more effective than hydromorphone in inhibiting thermal pain, and bupenorphine produces its antinociceptive effect by acting as an agonist at both mu- and kappa-spinal opioid receptors.
The Role of Spinal Opioid Receptors in Antinociceptive Effects Produced by Intrathecal Administration of Hydromorphone and Buprenorphine in the Rat
- Biology, MedicineAnesthesia and analgesia
- 2002
Intrathecally-administered hydromorphone and buprenorphine produced a dose- and time-dependent increase in the tail-flick response latency in rats, and naloxone administered intrathecally was effective in preventing the antinociceptive effects of subsequent intrathecal injections of bupenorphine.
Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and β-endorphin in mice
- BiologyNaunyn-Schmiedeberg's Archives of Pharmacology
- 2004
Results indicate that analgesia induced by morphine and DAMGO is mediated by the stimulation of mu-opioid receptors while analgesiainduced by DPDPE ismediated by the stimulating of delta-opIOid receptors.
Involvement of epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse.
- BiologyThe Journal of pharmacology and experimental therapeutics
- 1991
The present studies were designed to determine what types of opioid receptors and neurotransmitters were involved in inhibiting the tail-flick response induced by bremazocine in male ICR mice.